Results 301 to 310 of about 26,327 (353)
Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the
Daniela Tomasoni +17 more
wiley +1 more source
The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease. [PDF]
Morito T +16 more
europepmc +1 more source
Pharmacological management of heart failure. [PDF]
Gupta H, Verma R.
europepmc +1 more source
Impact of Angiotensin Receptor-Neprilysin Inhibitors on Patients With Acute Heart Failure Syndrome. [PDF]
Aristizabal-Colorado D +5 more
europepmc +1 more source
Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent. [PDF]
Nobili A, D'Amelio M.
europepmc +1 more source
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. [PDF]
Peikert A +17 more
europepmc +1 more source
Copper Downregulates Neprilysin Activity Through Modulation of Neprilysin Degradation [PDF]
Copper plays a central role in conserved processes such as respiration, and in highly specialized processes, such as protein modification. The metalloprotease neprilysin (NEP) degrades a variety of bioactive peptides and is involved in many physiological processes. However, very little is known about the regulation of NEP activity. In the current study,
Huan Yang +6 more
openaire +2 more sources

